Rivastigmine Transdermal System (Alvogen Inc.)
Welcome to the PulseAid listing for the Rivastigmine Transdermal System drug offered from Alvogen Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | Rivastigmine Transdermal System |
| SUBSTANCE NAME: | RIVASTIGMINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | PATCH, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-09-04 |
| END MARKETING DATE: | 0000-00-00 |
Rivastigmine Transdermal System HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rivastigmine Transdermal System from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4.6(mg/1) |
| START MARKETING DATE: | 2015-09-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-304_abf2cfa2-2c38-d01d-c450-70cdfffe5a9e |
| PRODUCT NDC: | 47781-304 |
| APPLICATION NUMBER: | ANDA204403 |
Other RIVASTIGMINE Pharmaceutical Manufacturers / Labelers:
